Get started
Author

Mélissa Bowerman

Observed names: Bowerman Melissa, Bowerman, Melissa, M Bowerman, M. Bowerman, MELISSA BOWERMAN, Melissa Bowerman, Mélissa Bowerman
Observed institutions: Ikerbasque, University of Ottawa, Inserm, University of the Basque Country, Université de Montpellier, Robert Jones and Agnes Hunt Orthopaedic Hospital, University of Oxford, Hôpital Gui de Chauliac, Institute for Neurosciences of Montpellier, Hôpital Saint Eloi, Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust, Université Montpellier 1, Ottawa Hospital Research Institute, Keele University
ORCID: 0000-0002-3579-6403
Observed ORCID: 0000-0002-3579-6403
OpenAlex ID: A5042843681
Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
2016 · Suzan M. Hammond, Gareth Hazell, et al. · Proceedings of the National Academy of Sciences · 193
PDF
Glucose metabolism and pancreatic defects in spinal muscular atrophy
2012 · Melissa Bowerman, Kathryn J. Swoboda, et al. · Annals of Neurology · 189
Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model
2010 · Mélissa Bowerman, Ariane Beauvais, et al. · Human Molecular Genetics · 177
PDF
A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology
2011 · Mélissa Bowerman, Lyndsay M. Murray, et al. · Neuromuscular Disorders · 148
Smn Depletion Alters Profilin II Expression and Leads to Upregulation of the RhoA/ROCK Pathway and Defects in Neuronal Integrity
2007 · Mélissa Bowerman, Dina Shafey, et al. · Journal of Molecular Neuroscience · 140
SMN, profilin IIa and plastin 3: A link between the deregulation of actin dynamics and SMA pathogenesis
2009 · Mélissa Bowerman, Carrie L. Anderson, et al. · Molecular and Cellular Neuroscience · 131
Abnormal fatty acid metabolism is a core component of spinal muscular atrophy
2019 · Marc‐Olivier Deguise, Giovanni Baranello, et al. · Annals of Clinical and Translational Neurology · 128
PDF
Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
2012 · Melissa Bowerman, Lyndsay M Murray, et al. · BMC Medicine · 127
PDF
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
2017 · Melissa Bowerman, Catherina G. Becker, et al. · Disease Models & Mechanisms · 120
PDF
Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
2017 · Matthew J.A. Wood, Kevin Talbot, et al. · Human Molecular Genetics · 77
PDF
Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology
2014 · Melissa Bowerman, John-Paul Michalski, et al. · Human Molecular Genetics · 66
PDF
Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis
2013 · Melissa Bowerman, Thierry Vincent, et al. · Frontiers in Cellular Neuroscience · 46
PDF
Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice
2018 · Lisa M. Walter, Marc-Olivier Deguise, et al. · EBioMedicine · 43
PDF
ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets
2014 · Emmanuelle Coque, Cédric Raoul, et al. · Frontiers in Neuroscience · 40
PDF
A SMNΔ7 read-through product confers functionality to the SMNΔ7 protein
2008 · Virginia B. Mattis, Melissa Bowerman, et al. · Neuroscience Letters · 37
Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development
2017 · Melissa Bowerman, Lyndsay M. Murray, et al. · European Journal of Medical Genetics · 35
PDF
Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis
2015 · M. Bowerman, C. Salsac, et al. · Human Molecular Genetics · 34
PDF
The Relationship between Body Composition, Fatty Acid Metabolism and Diet in Spinal Muscular Atrophy
2021 · Katherine S. Watson, Imane Boukhloufi, et al. · Brain Sciences · 30
PDF
The many faces of SMN: deciphering the function critical to spinal muscular atrophy pathogenesis
2010 · Justin G Boyer, Mélissa Bowerman, et al. · Future Neurology · 25
Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
2021 · Audrey M. Winkelsas, Christopher Grunseich, et al. · Molecular Therapy — Nucleic Acids · 22
PDF
Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy
2021 · Katharina E. Meijboom, Viola Volpato, et al. · JCI Insight · 20
PDF
Multi-Study Proteomic and Bioinformatic Identification of Molecular Overlap between Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA)
2018 · Darija Šoltić, Melissa Bowerman, et al. · Brain Sciences · 16
PDF
Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice
2018 · Lisa M Walter, Christiane E Koch, et al. · Human Molecular Genetics · 14
PDF
Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice
2022 · Katharina E. Meijboom, Emma R. Sutton, et al. · Skeletal Muscle · 13
PDF
KCC3 loss-of-function contributes to Andermann syndrome by inducing activity-dependent neuromuscular junction defects
2017 · Melissa Bowerman, Céline Salsac, et al. · Neurobiology of Disease · 13
PDF
Works count: 69
Citation count: 2,039
H-index: 20
I10-index: 31
Year
Topic
Type